Governor’s Pharmacy Initiative: Legal & Operational Models Explained

Meta Description: A comprehensive guide to the legal frameworks and operational models of state-level Governor’s Pharmacy Initiatives (GPIs), exploring telepharmacy, public-private partnerships, and community pharmacy support programs to combat pharmacy deserts.

Table of Contents#

1. What Is the Governor’s Pharmacy Initiative (GPI)?
2. Core Legal Frameworks Governing GPIs 2.1 State Statutory Authority 2.2 Federal Compliance Requirements 2.3 Licensing and Scope of Practice Rules
3. Common Operational Models for GPIs 3.1 Publicly Owned State Pharmacy Model 3.2 Public-Private Partnership (PPP) Model 3.3 Telepharmacy Hub-and-Spoke Model 3.4 Community Pharmacy Expansion Grant Model 3.5 Side-by-Side Model Comparison
4. Key Compliance and Risk Mitigation Strategies
5. Real-World Success Example: Washington State’s Pharmacy Initiatives
6. Frequently Asked Questions
7. References

---

What Is the Governor’s Pharmacy Initiative (GPI)?#

A Governor’s Pharmacy Initiative is a state-level, executive-led public health program focused on three core goals:

• Reduce out-of-pocket prescription costs for low-income, uninsured, and underinsured residents.
• Expand pharmacy care access in designated pharmacy deserts (typically defined as areas with no pharmacy within a 10-mile radius for urban regions, or a 30-mile radius for rural regions).
• Extend clinical pharmacy services (such as vaccine administration, chronic disease medication management, and contraceptive prescribing) to underserved populations.

As of 2026, dozens of U.S. states have enacted or proposed legislative measures to protect community pharmacies, regulate Pharmacy Benefit Managers (PBMs), and fund direct pharmacy support programs to expand access to care.

---

Core Legal Frameworks Governing GPIs#

All GPIs must adhere to overlapping state and federal legal requirements to operate legally and qualify for public funding:

2.1 State Statutory Authority#

GPIs cannot be launched by a governor’s executive order alone in most states:

• Most programs require dedicated legislative appropriations to fund operations, bulk drug purchasing, and staff costs.
• Enabling legislation typically defines eligible patient populations, program mandates, and liability protections (e.g., professional liability coverage for private GPI partners).
• Many states pass supplementary laws to exempt GPI locations from local zoning restrictions if they are located in pharmacy deserts.

2.2 Federal Compliance Requirements#

GPIs must meet all federal pharmacy and public health rules:

• FDA Requirements: Adherence to drug safety, storage, and traceability rules under the Drug Supply Chain Security Act (DSCSA), with the final compliance deadline for small dispensers (25 or fewer FTEs) set for November 27, 2026.
• HIPAA: Full compliance with patient health data privacy and security rules for all patient records and telehealth consultations.
• Medicaid/Medicare Rules: Alignment with federal reimbursement guidelines for claims filed by GPI pharmacies, plus requirements to pass 340B drug pricing discount savings to eligible low-income patients.
• DEA Rules: Strict protocols for controlled substance storage, dispensing, and record-keeping, with additional requirements for telepharmacy controlled substance prescriptions.

2.3 Licensing and Scope of Practice Rules#

All GPI-affiliated operations must meet state Board of Pharmacy standards:

• All pharmacists and pharmacy technicians working for GPI programs must hold active, unexpired state licenses.
• Many states expand scope of practice for GPI pharmacists via formal Collaborative Practice Agreements (CPAs) that allow them to prescribe contraceptives, PrEP, adjust diabetes or hypertension medications, and administer routine vaccines without a prior physician order.
• All physical and telepharmacy GPI locations must hold active state pharmacy facility licenses, with regular inspections to confirm compliance with safety standards.

---

Common Operational Models for GPIs#

States select operational models based on their budget, existing pharmacy infrastructure, and core program goals:

3.1 Publicly Owned State Pharmacy Model#

In this model, public entities directly manage or fund pharmacy services, often within state-run or municipal facilities. While direct state-owned retail pharmacies open to the general public are extremely rare in the United States, states and local governments frequently operate pharmacies within state-run psychiatric hospitals, correctional facilities, or county-run public health department clinics (such as Cook County Health in Illinois or Los Angeles County health systems). These pharmacies employ pharmacists as public health workers to serve specific, vulnerable populations.

• Pros: Direct control over prescription pricing, ability to provide medications at little or no cost to eligible patients, targeted care for underserved populations.
• Cons: High administrative and operating costs, slower scaling due to public procurement rules.
• Use case: Many county health departments and state correctional systems run direct-service pharmacies to control medication costs for safety-net patients and inmates.

3.2 Public-Private Partnership (PPP) Model#

States contract with private pharmacy operators (such as independent community pharmacies, regional chains, or health systems) to deliver services or distribute low-cost medications. The state may provide bulk drug purchasing discounts, operational subsidies, or coordinated networks in exchange for private partners agreeing to capped out-of-pocket costs, extended hours, or clinical services in designated pharmacy deserts.

• Pros: Rapid scaling using existing commercial infrastructure; low capital startup costs; supports local independent businesses.
• Cons: Requires strict contract monitoring to ensure compliance and prevent fraud.
• Use case: In 2025, Maryland’s governor announced a public-private partnership with the non-profit pharmacy "Good Pill" to help distribute surplus, affordable prescription drugs to state residents under strict safety guidelines.

3.3 Telepharmacy Hub-and-Spoke Model#

A licensed pharmacist at a central "hub" pharmacy utilizes telecommunications to oversee registered pharmacy technicians at remote "spoke" locations (such as clinic kiosks, community centers, or rural retail storefronts). The remote technician prepares the medication, and the hub pharmacist verifies the prescription via audio/video feed and conducts the required patient consultation.

• Pros: Low overhead; allows a single pharmacist to serve multiple remote locations; crucial for areas with severe pharmacist shortages.
• Cons: Requires reliable broadband; requires state Board of Pharmacy regulations that permit remote dispensing.
• Use case: The North Dakota Telepharmacy Project, established in 2002 by North Dakota State University (NDSU), has successfully restored and retained pharmacy services in dozens of rural communities, serving as a national model for telepharmacy regulations.

3.4 Community Pharmacy Expansion Grant Model#

States provide grants or direct financial aid to independent pharmacies located in high-risk or underserved areas to prevent closures and encourage expansion of clinical services. These grants help cover operational expenses, technology upgrades (like telepharmacy equipment), or staff training.

• Pros: Directly prevents the creation of new pharmacy deserts; supports small business owners; flexible funding tailored to community needs.
• Cons: Requires ongoing funding sources and administrative oversight to verify grant compliance.
• Use case: In June 2026, Illinois Governor JB Pritzker announced a major initiative providing nearly $25 million in funding to 434 independent community pharmacies across the state. Under this program, eligible pharmacies received equal payments of$56,892, funded by fees levied on PBMs under the bipartisan Prescription Drug Affordability Act, to help pharmacies in rural and low-income areas remain open.

3.5 Side-by-Side Model Comparison#

---

Key Compliance and Risk Mitigation Strategies#

To avoid legal violations and ensure long-term program sustainability, GPI administrators should implement the following safeguards:

1. Quarterly Audits: Conduct independent financial and clinical audits to monitor for Medicaid fraud, drug diversion, and HIPAA violations.
2. Stakeholder Advisory Board: Include practicing pharmacists, patient advocates, tribal health leaders, and legal counsel to update program rules as regulatory and community needs change.
3. Public Eligibility Guidelines: Post clear, accessible patient eligibility requirements on public-facing program websites to avoid discrimination claims and reduce patient confusion.
4. Annual Staff Training: Mandate annual training for all GPI staff on federal and state pharmacy rules, cultural competency, and patient privacy protocols.

---

Real-World Success Example: Washington State’s Pharmacy Initiatives#

While Washington does not have a single program officially designated as the "Governor's Pharmacy Initiative," the state has pioneered a comprehensive set of executive and legislative pharmacy initiatives that serve as a model for patient access and pharmacist scope of practice.

Washington was the first state in the nation to require commercial health insurance plans to include pharmacists in their medical provider networks under the landmark law ESSB 5557 (passed in 2015). This allowed pharmacists to bill for clinical services (like chronic disease management, diabetes education, and wellness counseling) rather than just dispensing fees. Washington pharmacists also widely utilize Collaborative Practice Agreements (CPAs) to prescribe contraceptives, PrEP/PEP, and vaccines. To further protect patient access and network adequacy, Washington enacted SB 5213 in 2026, placing strict regulations on Pharmacy Benefit Managers (PBMs).

These initiatives have delivered the following real-world results:

• Provider Status Integration: Pharmacists have successfully integrated into care teams, allowing clinics to bill for pharmacist-led chronic disease management.
• Expanded Access to Care: The widespread use of CPAs has significantly expanded access to preventive care, contraceptive prescribing, and immunizations, particularly in rural and underserved areas.
• PBM Transparency and Network Protections: Strict rules under SB 5213 ensure that PBMs cannot enforce restrictive network practices that drive independent pharmacies out of business, protecting critical access points.

---

Frequently Asked Questions#

Q: Who is eligible for GPI services?#

A: Eligibility varies by state, but most programs serve Medicaid/Medicare enrollees, uninsured residents, low-income households, and residents of designated pharmacy deserts.

Q: Do GPIs compete with private pharmacies?#

A: No. The vast majority of state-level pharmacy initiatives are designed to support and partner with existing private pharmacies (especially independent community pharmacies in rural and low-income areas) through grants, PBM reforms, and collaborative networks, rather than operating competing state-run locations.

Q: How are GPIs funded?#

A: Funding mechanisms vary. For example, the Illinois Pharmacy Support Program of 2026 is funded by fees levied on PBMs. Other state initiatives utilize state general funds, federal public health grants, and partnerships with non-profit entities or 340B drug pricing savings.

Q: Can GPIs dispense controlled substances?#

A: Yes, as long as they follow DEA and state Board of Pharmacy rules. Under federal law, dispensing controlled substances via telepharmacy typically requires complying with Ryan Haight Act provisions, including establishing a valid provider-patient relationship.

---

References#

1. Kaiser Family Foundation (KFF). (2024). Public Opinion on Prescription Drugs and Their Prices.
2. National Academy for State Health Policy (NASHP). (2026). State Laws Passed to Lower Prescription Drug Costs.
3. Illinois Governor's Office. (2026). Governor Pritzker Announces $25 Million Illinois Pharmacy Support Program.
4. North Dakota State University (NDSU) Center for Rural Health. (2024). The North Dakota Telepharmacy Project: Overview and Implementation.
5. Washington State Legislature. (2015). Senate Bill 5557 - Pharmacist Provider Status.
6. Washington State Legislature. (2026). Senate Bill 5213 - Regulating Pharmacy Benefit Managers.
7. U.S. Food and Drug Administration (FDA). (2025). Drug Supply Chain Security Act (DSCSA) Exemption and Compliance Guidelines.